Faruqi & Faruqi Investigates Securities Fraud Claims Against Multiple Companies

Faruqi & Faruqi, LLP is actively investigating potential securities class action lawsuits against several companies, including Merck, ModivCare, Intellia Therapeutics, and Arconic, due to alleged violations of federal securities laws. Investors who suffered significant financial losses are encouraged to contact the firm to discuss their legal options. Allegations against these companies include making false or misleading statements about financial health and business prospects, which led to investor losses. Additionally, the Schall Law Firm has filed a class action lawsuit against BioAge Labs for similar violations, citing false claims regarding the safety and efficacy of its lead trial candidate, azelaprag. Affected investors are urged to join these lawsuits to potentially recover their losses. Both firms emphasize the importance of acting before specific deadlines to secure a role as lead plaintiffs in these cases.